Haloperidol vs Conventional Therapy for Gastroparesis

Stopped early · Phase 4

Conditions studied: Gastroparesis

In brief

Randomized controlled trial comparing haloperidol combined with conventional therapy and conventional therapy alone in patients with symptomatic gastroparesis.

Key facts

Study ID

NCT02057549

Run by

The University of Texas Health Science Center, Houston

People needed

36

Starts

2012-11-01

Expected to finish

2016-11-01

Last updated by the study team

2017-08-17

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Previous diagnosis of GP including those without formal gastric emptying studies.
• Patients presenting with unresolving nausea, vomiting, and abdominal pain that is attributable to their GP.

You may not qualify if…

• History of QT prolongation or presence on a 12 leads electrocardiogram.
• Presence of concomitant acute abdominal pathology including but not limited to hepatobiliary disease, ischemia, and abdominal aneurysm.
• Prisoners
• Hypotension (systolic blood pressure below 90 mm Hg)
• Pregnant women
• Patients who are cognitively impaired and/or unable to consent for the study
• Age <18
• Allergy to haloperidol

Where it is running

• Lyndon Baines Johnson General Hospital — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.